Biotechs AIM for alternative financing: London's lesser-known stock exchange offers the possibility of money for hungry biotechs

Article Abstract:

US biotech companies are raising money through IPOs on London's Alternative Investment Market, (AIM) which was set up to create a financial marketplace where small and speculative companies could find backing since they find it difficult to find finance despite having very good technology. While AIM offers biotechs the potential of cash and few regulatory strings, it still has its risks since analyst coverage of AIM stocks is light and past bad experiences.

United Kingdom, Services information, Securities issued, listed, Services, International aspects, Securities, Company securities, Alternative Investment Management Association

---

Ramping up tech transfer

Article Abstract:

The measures that are being taken to use the inventions of the universities and research centers of the Greater Philadelphia region in developing its biotech and pharmaceutical businesses are discussed.

Analysis, Economic aspects, Philadelphia, Pennsylvania, Technology transfer

---

Ben Franklin Technology Partners of Southeastern Pennsylvania

Article Abstract:

The Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) is a regional nonprofit organization, which provides expertise and capital to other companies for their growth.

SOCIAL SERVICES, Social Assistance, Religious, Grantmaking, Civic, Professional, and Similar Organizations, Nonprofit Institutions, Social Services & Nonprofit Institutns, Nonprofit organizations

Similar abstracts:

• Abstracts: Separating nurture from nature in estimating heritability. A multivariate model for ordinal trait analysis. A penalized maximum likelihood method for estimating epistatic effects of QTL
• Abstracts: A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Getting downstream without a Raft
• Abstracts: Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development
• Abstracts: Reduction of soluble and insoluble iron forms by membrane fractions of Shewanella oneidensis grown under aerobic and anaerobic conditions
• Abstracts: Merck's fall from grace. Getting together on genomics. Daniel Skovronsky: a physician-scientist and business leader

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.